Sinusitis: New practice parameter tackles antimicrobial use

Most upper respiratory infections that you see in the office are viral; treating them with antibiotics is, of course, pointless. Sinusitis is a different kettle of fish, however: It causes more discomfort than a run-of-the-mill cold, lasts longer, is often bacterial, and is properly treated with antibiotics.

So that is the quandary: Is antibiotic treatment for a patient whose symptoms might be sinusitis a reasonable choice or just an injudicious use of antibiotics? An updated sinusitis practice parameter from the American Academy of Allergy, Asthma, and Immunology (AAAAI) offers some guidance:

The full text of the practice parameter is in the December 2005 issue of the Journal of Allergy and Clinical Immunology (also at

Related Videos
Benjamin Maxwell, MD, chief of child and adolescent psychiatry, Rady Children’s Hospital, San Diego, California | Image provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx -
Pfizer's infant RSV vaccine receives FDA Advisory Committee's support | Image Credit: Dr_Microbe - Image Credit: Dr_Microbe
Thomas R. Young, MD | Image Credit: Author provided
J. Thomas Megerian, MD, PhD, FAAP | Author provided
© 2023 MJH Life Sciences

All rights reserved.